봉약침을 이용한 ASCUS 치험 2례 = A report of Atypical squamous cells of undetermined significance(ASCUS) treated by Bee Venom Therapy

다국어 초록 (Multilingual Abstract)

Purpose : ASCUS is a diagnosis of exclusion for cytopathologic findings. ASCUS is not synonymous with previously used terms such as atypia,　"benign atypia", "inflammatory atypia",　or "reactive atypia",　which had included lesions currently classified in Bethesda System as reactive cellular changes. Most of these mild abnormalities will go away without treatment. So, there is no definitive treatment. The options are colposcopy and biopsy; repeat Pap tests at four-to-six month intervals, with colposcopy if the results continue to be abnormal; or triage using DNA testing for cancer-associated human papillomavirus types. However the entire SCJ(squamocolumnar junction) with early metaplasia cells is more susceptible to oncogenic factors, which may cause these cells to transform in to CIN. The main purpose of this clinical studies are to investigate
the effect of Bee Venom Therapy on ASCUS.
Methods : We researched two patients of ASCUS who were treated at CHA Gynecologic Oncology Center from 2002. 2 to 2002. 5. For that period they was treated with Bee Venom Therapy total twelve times.
Results : Two patients who were treated with Bee Venom Therapy recovered from ASCUS.
Conclusion : Bee Venom Therapy is effective to prevent ASCUS from progressing to CIN(Cervical Intraepithelial Neoplasia).

참고문헌 (Reference)

1 "자궁경부 세포진검사상 ASCUS로 확인된 환자에서 인유두종 바이러스검출의 임상적 의의" 40 (40): 260-365, 1997

2 "약침용 봉독액이 흑색종 세포에 미치는 항암효과에 대한 분자생물학적 연구" 17 (17): 169-188, 2000

3 "약침용 봉독성분중 Apamin, Mellitin의 항암작용" 18 (18): 129-145, 2001

4 "봉독침자극이 생쥐의 면역기능에 미치는 영향" 17 (17): 234-246, 1996

5 "봉독요법과 봉침요법" 한국교육기획 95-103, 1992

6 "봉독약침자극이 3-MCA 유발 상피종에 대한 항암 및 면역반응에 미치는 영향" 14 (14): 157-172, 1997

7 "봉독약침의 항암효과에 대한 분자생물학적 연구" 3 (3): 1-19, 2001

8 "Women's triage and managemnet preference for cervical cytologic repots demostrating ASCUS and LSIL" 6 (6): 48-354, 1997

9 "The Papanicolau test for cervical cancer detection a triumph and a tragedy" 261 : 737-743, 1989

10 "Suppressin or elevation of cytosolic phospholipase A2 alters keratinocy- teprostaglandin synthesis" 58 (58): 4624-4631, 1998

11 "Structure-antitumor and hemolytic activity relationships of synthetic peptid-esderived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides" 50 (50): 279-285, 1997

12 "Qualifiers of atypical squamous cells of undetermind significance help in patient management" 9 (9): 677-, 1996

13 "Predictive value of venom-specific IgE IgG AND IgG subclass antibodies in patients on immunotherapy with honey bee venom" 412-418, 1989

14 "Natural history of dysplasia of the uterine cervix Journal of the National Cancer Institute" 91 (91): 252-258, 1999

15 "Multiinstitutional study for development of cervical cancer screening model with new cervicography" 44 : 911-937, 2001

16 "Melitin-stimulated arachidonic acid metabolism by cultured malignant huan epidermal keratinocyte" 303-307, 1984

17 "Ion channel phenotype of melanoma cell lines" 155 (155): 27-34, 1997

18 "Inhibition by Melittin and fluphenazine od melanotropi receptor function and adenylate cyclase in melanoma cell menbranes" 121 (121): 1766-1772, 1987

19 "IgG antibody pattern during immunotherapy with honey bee venom" 222-229, 1987

20 "Enhanced bleomy-induced DNA damage and cytotoxicity with calmodulin antagonists" 27 (27): 387-393, 1985

21 "Current laboratory practices of participants in the College of American Pathologists interlaboratory comparison Archives of Pathology & Laboratory Medicine" 124 (124): 203-208, 2000

22 "Controversies in the management of low grade cervical intraepithelial neoplasia.Cancer" 71 : 1413-, 1993

23 "Clinical treatment of woman with atypical squamous cells of undetermind significance cervical cytology" 43 (43): 381-393, 2000

24 "Behavior of mild cervical dysplasia during long term follow up" 67 : 665-669, 1986